Driven by the Epsilon variant, cannabis sales at pharmacies reach a historic mark with high consumer preference for higher THC content

Partnership with TWA Brands foresees early purchase of products registered with Anvisa and marks the entry of the European company into Brazil

While the global index declines, the ETF MSOS accumulates significant gains in 2025, driven by expectations of changes in Section 280E

Financial consolidation, cultivation regulation, and strengthening of events mark the sector's prospects for the next year

Global Index falls by 4.2% during the year, but American operators diverge from the global scenario and show significant growth

Expert warns that the change in law alone does not guarantee exponential growth without banking reforms and institutional access

The possible reclassification of cannabis in the United States could expand access to credit, advertising, and ease tax burdens, opening up new opportunities for companies in the sector

Sector already generates €136 million, with over 500 stores and operating below potential due to outdated laws

Sector already generates €136 million, has over 500 stores, and operates below its potential due to outdated laws

The use of medical cannabis is rapidly growing in the United Kingdom, with increasing demand and increasingly potent products

New tool aims to streamline service in the medicinal cannabis market, connecting patients and specialists in real time to eliminate waiting lines

Proposal in the review of RDC 327/2019 to RDC 660/2022 divides opinions and raises doubts about access and judicialization